AskAt received a Notice before Acceptance dated July 1, 2024 from the Israel Patent Office (ILPO) for a salt and crystal forms patent for its CB2 agonist, AAT-730. The notice was issued in connection with Application Number 301333 (Filing Date: November 11, 2021). In addition to Israel, salt and crystal forms patents have also been granted in Australia, Brazil, Canada, China, Japan, Korea, Mexico, New Zealand, and the U.S.